Estimating the Dollar Value of Health Outcomes from Drug-Abuse Interventions

Michael French, Josephine A. Mauskopf, Jackqueline L. Teague, E. Joyce Roland

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

OBJECTIVES. People who abuse drugs suffer from a host of medical problems that impose costs on both the abusers and society as a whole. Drugabuse treatment and other interventions can help alleviate these medical problems, leading to health status improvements for chronic drug users and reduced social costs. The authors' dual purpose here is to (1) propose a theoretically rigorous yet easy-to-apply methodology for estimating the health-related costs of drug abuse and (2) demonstrate the methodology by estimating the potential dollar value of avoiding adverse health consequences as a result of successful drug-abuse interventions. METHODS. The authors' propsed multiattribute quality-adjusted life year methodology for estimating the value of avoiding morbidity and mortality involves eight steps to be followed sequentially. The framework is based on developing a common unit of well-being (ie, qualilty-adjusted life year) that can be applied to all types of health conditions. If all health states can be denominated in this common unit, then the process of valuation is straightforward and consistent across all types of illnesses and diseases. The methodology is relatively inexpensive to execute because the estimation procedures are not complicated technically and the data demands are modest. Also, this approach incorporates elements from several disciplines, including psychology, epidemiology, medicine, and economics. Finally, the proposed methodology is flexible enough to cover a wide range of illnesses and diseases so that consistent and comparable estimates can be generated. RESULTS. The authors estimate the dollor value of avoiding acute hepatitis B, human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), hypertension, bacterial pneumonia, sexually transmitted diseases, and tuberculosis for a white male aged 32 years. The authors' results illustrate that estimated avoided morbidity values can vary significantly across the range of health consequences associated with drug abuse. At the upper end of the range, the value of avoiding only the morbidity associated with a single case of HIV/AIDS is approximately $157,811 for the period beginning with transmission of HIV, through late-stage HIV and AIDS, and ending just before death. CONCLUSIONS. People who abuse drugs suffer from many medical problems in addition to their addiction. The proposed approach for estimating the dollar value of avoiding adverse health consequences provides policy analysts, evaluators, and researchers a method to calculate theoretically based benefit estimates for use in a benefit-cost analysis of drug-abuse interventions.

Original languageEnglish (US)
Pages (from-to)890-910
Number of pages21
JournalMedical Care
Volume34
Issue number9
StatePublished - Sep 1996
Externally publishedYes

Fingerprint

drug abuse
dollar
Substance-Related Disorders
health consequences
Health
health
HIV
morbidity
methodology
Acquired Immunodeficiency Syndrome
Quality-Adjusted Life Years
Morbidity
contagious disease
Bacterial Sexually Transmitted Diseases
illness
Disease
Bacterial Pneumonia
Costs and Cost Analysis
sexually transmitted disease
estimation procedure

Keywords

  • Benefit-cost analysis
  • Health valuation
  • Quality-adjusted life-year
  • Substance-abuse policy

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Nursing(all)
  • Health(social science)
  • Health Professions(all)

Cite this

French, M., Mauskopf, J. A., Teague, J. L., & Roland, E. J. (1996). Estimating the Dollar Value of Health Outcomes from Drug-Abuse Interventions. Medical Care, 34(9), 890-910.

Estimating the Dollar Value of Health Outcomes from Drug-Abuse Interventions. / French, Michael; Mauskopf, Josephine A.; Teague, Jackqueline L.; Roland, E. Joyce.

In: Medical Care, Vol. 34, No. 9, 09.1996, p. 890-910.

Research output: Contribution to journalArticle

French, M, Mauskopf, JA, Teague, JL & Roland, EJ 1996, 'Estimating the Dollar Value of Health Outcomes from Drug-Abuse Interventions', Medical Care, vol. 34, no. 9, pp. 890-910.
French M, Mauskopf JA, Teague JL, Roland EJ. Estimating the Dollar Value of Health Outcomes from Drug-Abuse Interventions. Medical Care. 1996 Sep;34(9):890-910.
French, Michael ; Mauskopf, Josephine A. ; Teague, Jackqueline L. ; Roland, E. Joyce. / Estimating the Dollar Value of Health Outcomes from Drug-Abuse Interventions. In: Medical Care. 1996 ; Vol. 34, No. 9. pp. 890-910.
@article{f9984f2e4c164cbab06f18c5a8105e59,
title = "Estimating the Dollar Value of Health Outcomes from Drug-Abuse Interventions",
abstract = "OBJECTIVES. People who abuse drugs suffer from a host of medical problems that impose costs on both the abusers and society as a whole. Drugabuse treatment and other interventions can help alleviate these medical problems, leading to health status improvements for chronic drug users and reduced social costs. The authors' dual purpose here is to (1) propose a theoretically rigorous yet easy-to-apply methodology for estimating the health-related costs of drug abuse and (2) demonstrate the methodology by estimating the potential dollar value of avoiding adverse health consequences as a result of successful drug-abuse interventions. METHODS. The authors' propsed multiattribute quality-adjusted life year methodology for estimating the value of avoiding morbidity and mortality involves eight steps to be followed sequentially. The framework is based on developing a common unit of well-being (ie, qualilty-adjusted life year) that can be applied to all types of health conditions. If all health states can be denominated in this common unit, then the process of valuation is straightforward and consistent across all types of illnesses and diseases. The methodology is relatively inexpensive to execute because the estimation procedures are not complicated technically and the data demands are modest. Also, this approach incorporates elements from several disciplines, including psychology, epidemiology, medicine, and economics. Finally, the proposed methodology is flexible enough to cover a wide range of illnesses and diseases so that consistent and comparable estimates can be generated. RESULTS. The authors estimate the dollor value of avoiding acute hepatitis B, human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), hypertension, bacterial pneumonia, sexually transmitted diseases, and tuberculosis for a white male aged 32 years. The authors' results illustrate that estimated avoided morbidity values can vary significantly across the range of health consequences associated with drug abuse. At the upper end of the range, the value of avoiding only the morbidity associated with a single case of HIV/AIDS is approximately $157,811 for the period beginning with transmission of HIV, through late-stage HIV and AIDS, and ending just before death. CONCLUSIONS. People who abuse drugs suffer from many medical problems in addition to their addiction. The proposed approach for estimating the dollar value of avoiding adverse health consequences provides policy analysts, evaluators, and researchers a method to calculate theoretically based benefit estimates for use in a benefit-cost analysis of drug-abuse interventions.",
keywords = "Benefit-cost analysis, Health valuation, Quality-adjusted life-year, Substance-abuse policy",
author = "Michael French and Mauskopf, {Josephine A.} and Teague, {Jackqueline L.} and Roland, {E. Joyce}",
year = "1996",
month = "9",
language = "English (US)",
volume = "34",
pages = "890--910",
journal = "Medical Care",
issn = "0025-7079",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Estimating the Dollar Value of Health Outcomes from Drug-Abuse Interventions

AU - French, Michael

AU - Mauskopf, Josephine A.

AU - Teague, Jackqueline L.

AU - Roland, E. Joyce

PY - 1996/9

Y1 - 1996/9

N2 - OBJECTIVES. People who abuse drugs suffer from a host of medical problems that impose costs on both the abusers and society as a whole. Drugabuse treatment and other interventions can help alleviate these medical problems, leading to health status improvements for chronic drug users and reduced social costs. The authors' dual purpose here is to (1) propose a theoretically rigorous yet easy-to-apply methodology for estimating the health-related costs of drug abuse and (2) demonstrate the methodology by estimating the potential dollar value of avoiding adverse health consequences as a result of successful drug-abuse interventions. METHODS. The authors' propsed multiattribute quality-adjusted life year methodology for estimating the value of avoiding morbidity and mortality involves eight steps to be followed sequentially. The framework is based on developing a common unit of well-being (ie, qualilty-adjusted life year) that can be applied to all types of health conditions. If all health states can be denominated in this common unit, then the process of valuation is straightforward and consistent across all types of illnesses and diseases. The methodology is relatively inexpensive to execute because the estimation procedures are not complicated technically and the data demands are modest. Also, this approach incorporates elements from several disciplines, including psychology, epidemiology, medicine, and economics. Finally, the proposed methodology is flexible enough to cover a wide range of illnesses and diseases so that consistent and comparable estimates can be generated. RESULTS. The authors estimate the dollor value of avoiding acute hepatitis B, human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), hypertension, bacterial pneumonia, sexually transmitted diseases, and tuberculosis for a white male aged 32 years. The authors' results illustrate that estimated avoided morbidity values can vary significantly across the range of health consequences associated with drug abuse. At the upper end of the range, the value of avoiding only the morbidity associated with a single case of HIV/AIDS is approximately $157,811 for the period beginning with transmission of HIV, through late-stage HIV and AIDS, and ending just before death. CONCLUSIONS. People who abuse drugs suffer from many medical problems in addition to their addiction. The proposed approach for estimating the dollar value of avoiding adverse health consequences provides policy analysts, evaluators, and researchers a method to calculate theoretically based benefit estimates for use in a benefit-cost analysis of drug-abuse interventions.

AB - OBJECTIVES. People who abuse drugs suffer from a host of medical problems that impose costs on both the abusers and society as a whole. Drugabuse treatment and other interventions can help alleviate these medical problems, leading to health status improvements for chronic drug users and reduced social costs. The authors' dual purpose here is to (1) propose a theoretically rigorous yet easy-to-apply methodology for estimating the health-related costs of drug abuse and (2) demonstrate the methodology by estimating the potential dollar value of avoiding adverse health consequences as a result of successful drug-abuse interventions. METHODS. The authors' propsed multiattribute quality-adjusted life year methodology for estimating the value of avoiding morbidity and mortality involves eight steps to be followed sequentially. The framework is based on developing a common unit of well-being (ie, qualilty-adjusted life year) that can be applied to all types of health conditions. If all health states can be denominated in this common unit, then the process of valuation is straightforward and consistent across all types of illnesses and diseases. The methodology is relatively inexpensive to execute because the estimation procedures are not complicated technically and the data demands are modest. Also, this approach incorporates elements from several disciplines, including psychology, epidemiology, medicine, and economics. Finally, the proposed methodology is flexible enough to cover a wide range of illnesses and diseases so that consistent and comparable estimates can be generated. RESULTS. The authors estimate the dollor value of avoiding acute hepatitis B, human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), hypertension, bacterial pneumonia, sexually transmitted diseases, and tuberculosis for a white male aged 32 years. The authors' results illustrate that estimated avoided morbidity values can vary significantly across the range of health consequences associated with drug abuse. At the upper end of the range, the value of avoiding only the morbidity associated with a single case of HIV/AIDS is approximately $157,811 for the period beginning with transmission of HIV, through late-stage HIV and AIDS, and ending just before death. CONCLUSIONS. People who abuse drugs suffer from many medical problems in addition to their addiction. The proposed approach for estimating the dollar value of avoiding adverse health consequences provides policy analysts, evaluators, and researchers a method to calculate theoretically based benefit estimates for use in a benefit-cost analysis of drug-abuse interventions.

KW - Benefit-cost analysis

KW - Health valuation

KW - Quality-adjusted life-year

KW - Substance-abuse policy

UR - http://www.scopus.com/inward/record.url?scp=0030240810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030240810&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - 890

EP - 910

JO - Medical Care

JF - Medical Care

SN - 0025-7079

IS - 9

ER -